Rockwell Medical, Inc.
NASDAQ:RMTI
3.475 (USD) • At close October 21, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 83.612 | 72.81 | 61.931 | 62.197 | 61.303 | 63.389 | 57.3 | 53.284 | 55.351 | 54.188 | 52.38 | 49.842 | 48.966 | 59.555 | 54.73 | 51.666 | 43.045 | 28.639 | 27.695 | 17.945 | 14.97 | 11.496 | 9.016 | 7.457 | 6.7 | 5.3 | 3.3 |
Cost of Revenue
| 74.908 | 68.733 | 64.351 | 59.472 | 58.464 | 64.973 | 53.598 | 46.532 | 46.413 | 45.643 | 45.72 | 43.149 | 43.323 | 49.694 | 46.842 | 48.649 | 40.015 | 25.837 | 24.69 | 15.139 | 12.414 | 10.042 | 8.103 | 6.098 | 5.4 | 5 | 3.5 |
Gross Profit
| 8.704 | 4.077 | -2.42 | 2.725 | 2.839 | -1.585 | 3.702 | 6.753 | 8.938 | 8.545 | 6.659 | 6.693 | 5.643 | 9.861 | 7.887 | 3.017 | 3.03 | 2.802 | 3.005 | 2.805 | 2.556 | 1.454 | 0.912 | 1.359 | 1.3 | 0.3 | -0.2 |
Gross Profit Ratio
| 0.104 | 0.056 | -0.039 | 0.044 | 0.046 | -0.025 | 0.065 | 0.127 | 0.161 | 0.158 | 0.127 | 0.134 | 0.115 | 0.166 | 0.144 | 0.058 | 0.07 | 0.098 | 0.109 | 0.156 | 0.171 | 0.126 | 0.101 | 0.182 | 0.194 | 0.057 | -0.061 |
Reseach & Development Expenses
| 1.107 | 3.119 | 6.835 | 7.092 | 6.886 | 6.742 | 6.321 | 5.84 | 4.961 | 7.784 | 39.382 | 48.272 | 17.805 | 3.422 | 6.454 | 3.83 | 3.264 | 4.778 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 12.142 | 15.644 | 15.348 | 16.182 | 20.998 | 23.082 | 23.303 | 21.121 | 19.079 | 18.321 | 14.336 | 12.684 | 9.522 | 9.308 | 6.914 | 7.272 | 3.374 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 2.125 | 2.094 | 5.733 | 7.871 | 9.05 | 1.005 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 14.267 | 17.738 | 21.081 | 24.053 | 30.048 | 23.082 | 23.303 | 21.121 | 19.079 | 18.321 | 14.336 | 12.684 | 9.522 | 9.308 | 6.914 | 7.272 | 3.374 | 2.661 | 2.868 | 2.396 | 2.368 | 2.319 | 2.353 | 2.024 | 2 | 1.9 | 1.4 |
Other Expenses
| 0 | 0 | 0 | -0.837 | -0.43 | -1.03 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.003 | 0 | 0.379 | 0.4 | 0.4 | 0.3 |
Operating Expenses
| 15.374 | 20.857 | 27.916 | 31.145 | 36.934 | 29.825 | 29.625 | 26.961 | 24.04 | 26.104 | 53.718 | 60.956 | 27.328 | 12.73 | 13.369 | 11.102 | 6.638 | 7.439 | 2.868 | 2.396 | 2.368 | 2.316 | 2.353 | 2.404 | 2.4 | 2.3 | 1.7 |
Operating Income
| -6.67 | -16.78 | -30.336 | -28.42 | -34.095 | -32.439 | -25.923 | -20.209 | -15.102 | -17.559 | -47.059 | -54.262 | -21.685 | -2.869 | -5.481 | -8.085 | -3.608 | -4.638 | 0.137 | 0.409 | 0.188 | -0.862 | -1.44 | -1.045 | -1.1 | -2 | -1.9 |
Operating Income Ratio
| -0.08 | -0.23 | -0.49 | -0.457 | -0.556 | -0.512 | -0.452 | -0.379 | -0.273 | -0.324 | -0.898 | -1.089 | -0.443 | -0.048 | -0.1 | -0.156 | -0.084 | -0.162 | 0.005 | 0.023 | 0.013 | -0.075 | -0.16 | -0.14 | -0.164 | -0.377 | -0.576 |
Total Other Income Expenses Net
| -1.769 | -1.899 | -2.338 | -2.47 | -0.033 | -1.252 | 0.001 | 0.81 | 0.682 | -3.768 | -1.724 | 0.241 | 0.242 | -0.019 | -0.02 | 0.221 | -0.111 | 0.063 | 0.137 | -0.198 | -0.183 | -0.003 | -0.049 | 0 | 0 | 0 | 0 |
Income Before Tax
| -8.439 | -18.679 | -32.674 | -30.89 | -34.128 | -32.126 | -25.921 | -19.398 | -14.42 | -21.327 | -48.783 | -54.022 | -21.443 | -2.683 | -5.501 | -7.864 | -3.719 | -4.575 | 0.077 | 0.212 | 0.005 | -0.981 | -1.579 | 0 | 0 | 0 | 0 |
Income Before Tax Ratio
| -0.101 | -0.257 | -0.528 | -0.497 | -0.557 | -0.507 | -0.452 | -0.364 | -0.261 | -0.394 | -0.931 | -1.084 | -0.438 | -0.045 | -0.101 | -0.152 | -0.086 | -0.16 | 0.003 | 0.012 | 0 | -0.085 | -0.175 | 0 | 0 | 0 | 0 |
Income Tax Expense
| 1.276 | 1.899 | 2.36 | 1.042 | -3.05 | 0.313 | -0.002 | 0.405 | 0 | 0.386 | 0.098 | 0.242 | 0.002 | -0.205 | 0 | 0 | 0 | 0 | 0.061 | 0 | 0 | 0.116 | 0.139 | -0.028 | 0 | -0.1 | 0 |
Net Income
| -8.439 | -20.578 | -35.034 | -31.932 | -31.078 | -32.126 | -25.921 | -19.803 | -14.42 | -21.327 | -48.783 | -54.022 | -21.445 | -2.683 | -5.501 | -7.864 | -3.719 | -4.575 | 0.077 | 0.212 | 0.005 | -0.981 | -1.579 | -1.017 | -1.1 | -1.9 | -1.9 |
Net Income Ratio
| -0.101 | -0.283 | -0.566 | -0.513 | -0.507 | -0.507 | -0.452 | -0.372 | -0.261 | -0.394 | -0.931 | -1.084 | -0.438 | -0.045 | -0.101 | -0.152 | -0.086 | -0.16 | 0.003 | 0.012 | 0 | -0.085 | -0.175 | -0.136 | -0.164 | -0.358 | -0.576 |
EPS
| -0.36 | -2.09 | -4.11 | -4.64 | -5.61 | -6.69 | -5.61 | -4.3 | -3.19 | -5.72 | -16.32 | -29.15 | -13.31 | -1.76 | -4.07 | -6.25 | -3.52 | -4.51 | 0.11 | 0.22 | 0.004 | -1.4 | -3.01 | -2.3 | -2.42 | -4.31 | -4.23 |
EPS Diluted
| -0.36 | -2.09 | -4.11 | -4.64 | -5.61 | -6.69 | -5.61 | -4.29 | -3.19 | -5.67 | -16.28 | -29.14 | -13.31 | -1.76 | -4.07 | -6.25 | -3.52 | -4.51 | 0.11 | 0.22 | 0.004 | -1.4 | -3.01 | -2.3 | -2.42 | -4.31 | -4.23 |
EBITDA
| -5.226 | -16.747 | -27.799 | -26.73 | -34.125 | -31.187 | -25.409 | -18.636 | -14.28 | -16.177 | -45.954 | -52.933 | -20.265 | -1.48 | -4.248 | -7.173 | -2.659 | -3.881 | 0.716 | 1.039 | 0.642 | -0.47 | -1.007 | -0.666 | -0.7 | -1.6 | -1.6 |
EBITDA Ratio
| -0.063 | -0.23 | -0.449 | -0.43 | -0.557 | -0.492 | -0.443 | -0.35 | -0.258 | -0.299 | -0.877 | -1.062 | -0.414 | -0.025 | -0.078 | -0.139 | -0.062 | -0.136 | 0.026 | 0.058 | 0.043 | -0.041 | -0.112 | -0.089 | -0.104 | -0.302 | -0.485 |